In vitro activity and selection of disk content for disk diffusion susceptibility tests with trovafloxacin
- PMID: 8894580
- DOI: 10.1007/BF01691159
In vitro activity and selection of disk content for disk diffusion susceptibility tests with trovafloxacin
Abstract
The activity of the new fluoroquinolone trovafloxacin (CP-99,219) was compared with that of ciprofloxacin and ofloxacin against 517 bacterial isolates representing 50 different species. Against members of the family Enterobacteriaceae, all three drugs showed good in vitro activity. Against most anaerobic bacteria, Staphylococcus, Streptococcus, and Enterococcus species, trovafloxacin was four- to sixteenfold more active than ciprofloxacin. For disk diffusion testing, 10 micrograms trovafloxacin disks gave satisfactory results. Tentative criteria are proposed for use during clinical studies.
Similar articles
-
In vitro activity of trovafloxacin against ciprofloxacin-susceptible and -resistant clinical bacterial isolates and assessment of the trovafloxacin disk test.Diagn Microbiol Infect Dis. 1999 Jan;33(1):33-8. doi: 10.1016/s0732-8893(98)00134-5. Diagn Microbiol Infect Dis. 1999. PMID: 9990473
-
Calibration of the disk diffusion test for trovafloxacin susceptibility testing of four anaerobic species.Clin Microbiol Infect. 2000 Apr;6(4):195-201. doi: 10.1046/j.1469-0691.2000.00031.x. Clin Microbiol Infect. 2000. PMID: 11168107
-
In-vitro activity of trovafloxacin, a new fluoroquinolone, against recent clinical isolates.J Antimicrob Chemother. 1997 Jun;39 Suppl B:43-9. doi: 10.1093/jac/39.suppl_2.43. J Antimicrob Chemother. 1997. PMID: 9222069
-
Trovafloxacin: fourth generation fluoroquinolone.Conn Med. 1998 Aug;62(8):483-7. Conn Med. 1998. PMID: 9753805 Review. No abstract available.
-
Recommendations of the Spanish Antibiogram Committee (COESANT) for in vitro susceptibility testing of antimicrobial agents by disk diffusion.Enferm Infecc Microbiol Clin (Engl Ed). 2023 Nov;41(9):571-576. doi: 10.1016/j.eimce.2022.12.009. Epub 2023 Jan 5. Enferm Infecc Microbiol Clin (Engl Ed). 2023. PMID: 36610835 Review.
Cited by
-
The new fluoroquinolones: A critical review.Can J Infect Dis. 1999 May;10(3):207-38. doi: 10.1155/1999/378394. Can J Infect Dis. 1999. PMID: 22346384 Free PMC article.
-
Ofloxacin otic solution: a review of its use in the management of ear infections.Drugs. 1999 Sep;58(3):509-31. doi: 10.2165/00003495-199958030-00019. Drugs. 1999. PMID: 10493278 Review.
-
Trovafloxacin concentrations in airway fluids of patients with severe community-acquired pneumonia.Antimicrob Agents Chemother. 2000 Jan;44(1):178-80. doi: 10.1128/AAC.44.1.178-180.2000. Antimicrob Agents Chemother. 2000. PMID: 10602743 Free PMC article.
-
Pharmacokinetics of [18F]trovafloxacin in healthy human subjects studied with positron emission tomography.Antimicrob Agents Chemother. 1998 Aug;42(8):2048-54. doi: 10.1128/AAC.42.8.2048. Antimicrob Agents Chemother. 1998. PMID: 9687405 Free PMC article.
-
Quality control limits for dilution and disk diffusion susceptibility tests of trovafloxacin against eight quality control strains.J Clin Microbiol. 1998 Feb;36(2):585-6. doi: 10.1128/JCM.36.2.585-586.1998. J Clin Microbiol. 1998. PMID: 9466783 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous